[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries: Global Cancer Statistics 2018. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
张浩洋, 曹毅, 徐玥, 等. 乙肝相关性肝癌患者根治性切除术预后影响因素Cox回归分析[J]. 中国公共卫生, 2017, 33(11): 110-113.
|
[3]
|
程书蕙, 陈波, 李晔雄. 原发性肝癌术后辅助治疗的研究进展[J]. 中华放射肿瘤学杂志, 2019, 28(3): 233-237.
|
[4]
|
梅俊. 腹腔镜肝切除与开腹肝切除治疗原发性肝细胞癌临床研究[J]. 肝胆外科杂志, 2018, 26(1): 23-26.
|
[5]
|
Erstad, D.J. and Tanabe, K.K. (2019) Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma. Annals of Surgical Oncology, 26, 812-820. https://doi.org/10.1245/s10434-019-07227-9
|
[6]
|
Zhang, X., Li, J., Shen, F., et al. (2017) Significance of Presence of Microvascular Invasion in Specimens Obtained after Surgical Treatment of Hepatocellular Carcinoma. Journal of Gastroenterology & Hepatology, 33, 347-354.
https://doi.org/10.1111/jgh.13843
|
[7]
|
Vogel, A. and Saborowski, A. (2020) Current Strategies for the Treatment of Intermediate and Advanced Hepatocellular Carcinoma. Cancer Treatment Reviews, 82, Article ID: 101946. https://doi.org/10.1016/j.ctrv.2019.101946
|
[8]
|
Sayiner, M., Golabi, P. and Younossi, Z.M. (2019) Disease Burden of Hepatocellular Carcinoma: A Global Perspective. Digestive Diseases and Sciences, 64, 910-917. https://doi.org/10.1007/s10620-019-05537-2
|
[9]
|
Bertuccio, P., Turati, F., Carioli, G., et al. (2017) Global Trends and Predictions in Hepatocellular Carcinoma Mortality. Journal of Hepatology, 67, 302-309. https://doi.org/10.1016/j.jhep.2017.03.011
|
[10]
|
Xu, X., Chen, J., Wei, Q., et al. (2019) Clinical Practice Guidelines on Liver Transplantation for Hepatocellular Carcinoma in China (2018 Edition). Hepatobiliary & Pancreatic Diseases International, 18, 307-312.
https://doi.org/10.1016/j.hbpd.2019.06.010
|
[11]
|
邓天芝, 陈晓梅, 龙洪航. 腹腔镜肝癌切除术对原发性肝癌患者血清恶性生物学指标及术后康复的影响[J]. 成都医学院学报, 2019, 14(1): 88-92.
|
[12]
|
欧阳正晟, 唐朝晖, 吕丽娟, 等. 腹腔镜肝切除与开腹肝切除治疗原发性肝癌的临床比较[J]. 中国普通外科杂志, 2017, 26(1): 126-130.
|
[13]
|
周皓岚, 贾贵清, 付英, 等. 腹腔镜肝癌切除术对原发性肝癌患者血清生物学指标及术后康复的影响[J]. 检验医学与临床, 2019, 16(10): 15-18.
|
[14]
|
张成武. 腹腔镜肝切除术治疗原发性肝癌[J]. 浙江医学, 2019, 41(17): 1808-1811.
|
[15]
|
Reich, H., Mcglynn, F., Decaprio, J., et al. (1991) Laparoscopic Excision of Benign Liver Lesions. Obstetrics and Gynecology, 78, 956-958.
|
[16]
|
胡泽明, 陈彪, 钟佳宁, 等. 原发性肝癌治疗方法的应用进展[J]. 山东医药, 2019, 59(9): 106-110.
|
[17]
|
Tan, T.C., Han, H.S., She, W.H., et al. (2018) The Asia Pacific Consensus Statement on Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Report from the 7th Asia-Pacific Primary Hepatocellular Carcinoma Expert Meeting Held in Hong Kong. Hepatocellular Carcinoma, 7, 28-39. https://doi.org/10.1159/000481834
|
[18]
|
胡继科, 李雪梅, 张凡, 等. 肝癌术后复发危险因素影响研究进展[J]. 中华肝胆外科杂志, 2018, 24(9): 644-648.
|
[19]
|
宋书红, 郭俊, 邹灿, 等. 肝癌手术切除术后复发相关因素分析[J]. 实用肝脏病杂志, 2017, 20(2): 79-82.
|
[20]
|
蒋亚波, 郭卫星, 程树群. 肝细胞癌伴门静脉癌栓发生机制的研究进展[J]. 中国细胞生物学学报, 2017, 39(2): 244-249.
|
[21]
|
Goh, P.K., et al. (2014) 336. Number of Nodules, Child-Pugh Status, Margin Positivity and Microvascular Invasion but Not Tumour Size Are Prognostic Factors of Survival after Liver Resection for Multifocal Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery, 18, 1477-1485. https://doi.org/10.1016/j.ejso.2014.08.326
|
[22]
|
Yang, P., Si, A., Yang, J., et al. (2018) A Wide-Margin Liver Resection Improves Long-Term Outcomes for Patients with HBV-Related Hepatocellular Carcinoma with Microvascular Invasion. Surgery, 165, 721-730.
https://doi.org/10.1016/j.surg.2018.09.016
|
[23]
|
Pommergaard, H.-C., et al. (2018) Vascular Invasion and Survival after Liver Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry. HPB (Oxford), 20, 768-775.
|
[24]
|
胡月雷, 孙大伟, 骆飞翔, 等. 单发肝细胞癌发生微血管侵犯的影响因素及预后分析[J]. 临床肝胆病杂志, 2018, 34(9): 1911-1916.
|
[25]
|
Sumie, S., Kuromatsu, R., Okuda, K., et al. (2008) Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological Factors. Annals of Surgical Oncology, 15, 1375-1382.
https://doi.org/10.1245/s10434-008-9846-9
|
[26]
|
Zhang, W., Liu, L., Wang, P., et al. (2018) Preoperative Computed Tomography and Serum α-Fetoprotein to Predict Microvascular Invasion in Hepatocellular Carcinoma. Medicine, 97, e11402.
https://doi.org/10.1097/MD.0000000000011402
|
[27]
|
Renzulli, M., Brocchi, S., CuCcHetti, A., et al. (2015) Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma? Radiology, 279, Article ID: 150998.
https://doi.org/10.1148/radiol.2015150998
|
[28]
|
Segal, E., Sirlin, C.B., Ooi, C., et al. (2007) Decoding Global Gene Expression Programs in Hepatocellular Carcinoma by Noninvasive Imaging. Nature Biotechnology, 25, 675-680.
|
[29]
|
Banerjee, S., et al. (2015) A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma. Hepatology, 62, 792-800. https://doi.org/10.1002/hep.27877
|
[30]
|
Lee, S., Kim, S.H., Ji, E.L., et al. (2017) Preoperative Gadoxetic Acid-Enhanced MRI for Predicting Microvascular Invasion in Patients with Single Hepatocellular Carcinoma. Journal of Hepatology, 67, 526-534.
https://doi.org/10.1016/j.jhep.2017.04.024
|
[31]
|
陈培培, 陆健, 张涛, 等. 钆塞酸二钠增强MRI对肝细胞癌微血管侵犯的预测价值[J]. 中华放射学杂志, 2019, 53(2): 103-108.
|
[32]
|
Hyun, S.H., Eo, J.S., Song, B.I., et al. (2017) Preoperative Prediction of Microvascular Invasion of Hepatocellular Carcinoma Using 18F-FDG PET/CT: A Multicenter Retrospective Cohort Study. European Journal of Nuclear Medicine and Molecular Imaging, 45, 720-726. https://doi.org/10.1007/s00259-017-3880-4
|
[33]
|
Koizumi, S., Yamashita, S., Matsumura, S., et al. (2020) Significance of a Preoperative Tumor Marker Gradient for Predicting Microvascular Invasion in Cases of Hepatocellular Carcinoma. Molecular and Clinical Oncology, 12, 290-294. https://doi.org/10.3892/mco.2020.1975
|
[34]
|
Lei, Z., Li, J., Dong, W., et al. (2016) Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma within the Milan Criteria. JAMA Surgery, 151, 356-363.
https://doi.org/10.1001/jamasurg.2015.4257
|
[35]
|
Imura, S., Teraoku, H., Yoshikawa, M., et al. (2017) Potential Predictive Factors for Microvascular Invasion in Hepatocellular Carcinoma Classified within the Milan Criteria. International Journal of Clinical Oncology, 23, 1-6.
https://doi.org/10.1007/s10147-017-1189-8
|
[36]
|
Poté, N., Cauchy, F., Albuquerque, M., et al. (2015) Performance of PIVKA-II for Early Hepatocellular Carcinoma Diagnosis and Prediction of Microvascular Invasion. Journal of Hepatology, 62, 848-854.
https://doi.org/10.1016/j.jhep.2014.11.005
|
[37]
|
Chen, L., Zhang, Q., Chang, W., et al. (2012) Viral and Host Inflammation-Related Factors That Can Predict the Prognosis of Hepatocellular Carcinoma. European Journal of Cancer, 48, 1977-1987.
https://doi.org/10.1016/j.ejca.2012.01.015
|
[38]
|
Ryu, S.H., et al. (2010) Metastatic Tumor Antigen 1 Is Closely Associated with Frequent Postoperative Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma. Hepatology, 47, 929-936.
|
[39]
|
Bui-Nguyen, T.M., Pakala, S.B., Sirigiri, R.D., et al. (2010) NF-κB Signaling Mediates the Induction of MTA1 by Hepatitis B Virus Transactivator Protein HBx. Oncogene, 29, 1179-1189. https://doi.org/10.1038/onc.2009.404
|
[40]
|
Yang, P., Li, Q.-J., Feng, Y., et al. (2012) TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma. Cancer Cell, 22, 291-303.
https://doi.org/10.1016/j.ccr.2012.07.023
|
[41]
|
杜培源, 宋京海, 乔江春, 等. 肝细胞癌患者微血管侵犯影响因素分析[J]. 中华肝胆外科杂志, 2019, 25(1): 26-29.
|
[42]
|
Pawlik, T., Delman, K., Vauthey, J., et al. (2010) Tumor Size Predicts Vascular Invasion and Histologic Grade: Implications for Selection of Surgical Treatment for Hepatocellular Carcinoma. Liver Transplantation, 11, 1086-1092.
https://doi.org/10.1002/lt.20472
|
[43]
|
曹国良, 蔡庆, 李幼安, 等. 肝细胞癌微血管侵犯的危险因素分析及预后[J]. 中华消化外科杂志, 2017(16): 1048-1052.
|
[44]
|
Yin, C.Q., Yuan, C.H., Zhen, Q., et al. (2016) Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers. Disease Markers, 2016, Article ID: 1427849. https://doi.org/10.1155/2016/1427849
|